• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型抗内脏利什曼病化疗药物的寄生虫学和免疫学评价。

Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis.

机构信息

Programa de Pós-Graduação em Ciências da Saúde: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.

Departamento de Ciências Biológicas, Insituto de Ciências Exatas e Biológicas, Universidade Federal de Ouro Preto, Ouro Preto, Minas Gerais, Brazil.

出版信息

Parasite Immunol. 2020 Dec;42(12):e12784. doi: 10.1111/pim.12784. Epub 2020 Aug 30.

DOI:10.1111/pim.12784
PMID:32772379
Abstract

AIMS

Treatment for visceral leishmaniasis (VL) is hampered by the toxicity and/or high cost of drugs, as well as by emergence of parasite resistance. Therefore, there is an urgent need for new antileishmanial agents.

METHODS AND RESULTS

In this study, the antileishmanial activity of a diprenylated flavonoid called 5,7,3,4'-tetrahydroxy-6,8-diprenylisoflavone (CMt) was tested against Leishmania infantum and L amazonensis species. Results showed that CMt presented selectivity index (SI) of 70.0 and 165.0 against L infantum and L amazonensis promastigotes, respectively, and of 181.9 and 397.8 against respective axenic amastigotes. Amphotericin B (AmpB) showed lower SI values of 9.1 and 11.1 against L infantum and L amazonensis promastigotes, respectively, and of 12.5 and 14.3 against amastigotes, respectively. CMt was effective in the treatment of infected macrophages and caused alterations in the parasite mitochondria. L infantum-infected mice treated with miltefosine, CMt alone or incorporated in polymeric micelles (CMt/Mic) presented significant reductions in the parasite load in distinct organs, when compared to the control groups. An antileishmanial Th1-type cellular and humoral immune response were developed one and 15 days after treatment, with CMt/Mic-treated mice presenting a better protective response.

CONCLUSION

Our data suggest that CMt/Mic could be evaluated as a chemotherapeutic agent against VL.

摘要

目的

内脏利什曼病(VL)的治疗受到药物毒性和/或高成本以及寄生虫耐药性出现的阻碍。因此,迫切需要新的抗利什曼原虫药物。

方法和结果

在这项研究中,测试了一种被称为 5,7,3,4'-四羟基-6,8-二异戊烯基异黄酮(CMt)的双异戊烯基化黄酮对利什曼原虫和 L amazonensis 种的抗利什曼原虫活性。结果表明,CMt 对 L infantum 和 L amazonensis 前鞭毛体的选择性指数(SI)分别为 70.0 和 165.0,对相应的无环阿米巴体的 SI 分别为 181.9 和 397.8。两性霉素 B(AmpB)对 L infantum 和 L amazonensis 前鞭毛体的 SI 值分别为 9.1 和 11.1,对无环阿米巴体的 SI 值分别为 12.5 和 14.3。CMt 对感染的巨噬细胞有效,并导致寄生虫线粒体发生变化。与对照组相比,用米替福新、CMt 单独或掺入聚合物胶束(CMt/Mic)治疗的感染 L infantum 的小鼠在不同器官中的寄生虫负荷显著降低。在治疗后 1 天和 15 天,产生了抗利什曼原虫 Th1 型细胞和体液免疫反应,用 CMt/Mic 治疗的小鼠表现出更好的保护反应。

结论

我们的数据表明,CMt/Mic 可作为治疗内脏利什曼病的化疗药物进行评估。

相似文献

1
Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis.一种新型抗内脏利什曼病化疗药物的寄生虫学和免疫学评价。
Parasite Immunol. 2020 Dec;42(12):e12784. doi: 10.1111/pim.12784. Epub 2020 Aug 30.
2
Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.对一种氯喹啉衍生物针对能够引起皮肤利什曼病和内脏利什曼病的利什曼原虫物种的体外和体内抗利什曼活性进行评估。
Exp Parasitol. 2019 Apr;199:30-37. doi: 10.1016/j.exppara.2019.02.019. Epub 2019 Feb 25.
3
Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis.阿卡波糖具有抗利什曼原虫的体外和体内活性,是一种有前途的内脏利什曼病治疗候选药物。
Med Microbiol Immunol. 2021 Jun;210(2-3):133-147. doi: 10.1007/s00430-021-00707-4. Epub 2021 Apr 18.
4
Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis.洋地黄毒苷元对婴儿利什曼原虫具有有效且选择性的抗利什曼原虫作用,是内脏利什曼病的一种潜在治疗药物。
Parasitol Res. 2021 Jan;120(1):321-335. doi: 10.1007/s00436-020-06971-2. Epub 2020 Nov 16.
5
In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.一种氟喹诺酮衍生物对婴儿利什曼原虫和亚马逊利什曼原虫的体外和体内抗利什曼活性。
Acta Trop. 2019 Mar;191:29-37. doi: 10.1016/j.actatropica.2018.12.036. Epub 2018 Dec 23.
6
Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis.伊维菌素在体外和体内对利什曼原虫具有有效和选择性的抗利什曼活性,并具有治疗内脏利什曼病的作用。
Exp Parasitol. 2021 Feb;221:108059. doi: 10.1016/j.exppara.2020.108059. Epub 2020 Dec 16.
7
Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species.氯碘羟喹对利什曼原虫和亚马逊利什曼原虫种的抗利什曼原虫活性、细胞毒性和作用机制。
Basic Clin Pharmacol Toxicol. 2018 Sep;123(3):236-246. doi: 10.1111/bcpt.12990. Epub 2018 Apr 6.
8
Treatment using vanillin-derived synthetic molecules incorporated into polymeric micelles is effective against infection caused by Leishmania amazonensis species.使用掺入聚合物胶束中的香草醛衍生合成分子进行治疗,对亚马逊利什曼原虫引起的感染有效。
Exp Parasitol. 2024 May;260:108743. doi: 10.1016/j.exppara.2024.108743. Epub 2024 Mar 19.
9
Poloxamer 407 (Pluronic(®) F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis.基于泊洛沙姆407(普朗尼克(®)F127)的两性霉素B聚合物胶束:体外生物活性、毒性及对小鼠皮肤利什曼病的体内治疗效果
Exp Parasitol. 2016 Oct;169:34-42. doi: 10.1016/j.exppara.2016.07.005. Epub 2016 Jul 15.
10
A Pluronic® F127-based polymeric micelle system containing an antileishmanial molecule is immunotherapeutic and effective in the treatment against Leishmania amazonensis infection.一种含有抗利什曼原虫分子的基于普朗尼克® F127的聚合物胶束系统具有免疫治疗作用,对治疗亚马逊利什曼原虫感染有效。
Parasitol Int. 2019 Feb;68(1):63-72. doi: 10.1016/j.parint.2018.10.005. Epub 2018 Oct 16.

引用本文的文献

1
Antileishmanial Activities of Medicinal Herbs and Phytochemicals In Vitro and In Vivo: An Update for the Years 2015 to 2021.抗利什曼原虫草药和植物化学物质的体外和体内抗利什曼原虫活性:2015 至 2021 年的更新。
Molecules. 2022 Nov 4;27(21):7579. doi: 10.3390/molecules27217579.
2
Use of Natural Products in Leishmaniasis Chemotherapy: An Overview.天然产物在利什曼病化疗中的应用:综述
Front Chem. 2020 Nov 23;8:579891. doi: 10.3389/fchem.2020.579891. eCollection 2020.